In today’s recent session, 81.78 million shares of the Aptevo Therapeutics Inc (NASDAQ:APVO) have been traded, and its beta is 5.73. Most recently the company’s share price was $6.88, and it changed around $4.06 or 143.97% from the last close, which brings the market valuation of the company to $5.20M. APVO at last check was trading at a discount to its 52-week high of $485.37, offering almost -6954.8% off that amount. The share price’s 52-week low was $2.81, which indicates that the recent value has risen by an impressive 59.16% since then. We note from Aptevo Therapeutics Inc’s average daily trading volume that its 10-day average is 96030.0 shares, with the 3-month average coming to 279.57K.
Aptevo Therapeutics Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended APVO as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Aptevo Therapeutics Inc (NASDAQ:APVO) trade information
Instantly APVO has been showing a green trend so far today with a performance of 143.97% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 13.11 on recent trading dayincreased the stock’s daily price by 47.52%. The company’s shares are currently down -92.02% year-to-date, but still up 47.96% over the last five days. On the other hand, Aptevo Therapeutics Inc (NASDAQ:APVO) is 10.97% up in the 30-day period. We can see from the shorts that 9397.0 shares have been sold at a short interest cover period of 0.03 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 80.96%.
APVO Dividends
Aptevo Therapeutics Inc’s next quarterly earnings report is expected to be released on 2025-May-15.
Aptevo Therapeutics Inc (NASDAQ:APVO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 3.11% of Aptevo Therapeutics Inc shares, and 3.31% of them are in the hands of institutional investors. The stock currently has a share float of 3.41%.